1 citations
,
May 2021 in “InterConf” This publication discusses the potential mechanisms behind telogen alopecia as a dermatological manifestation of post-COVID-19 syndrome and reports no new clinical results.
May 2026 in “Skin Appendage Disorders” This study identified distinct trichoscopic and histopathological features of telogen effluvium following COVID-19 infection, with trichoscopic vascular patterns correlating with the severity of the initial infection.
January 2025 in “Dermatology Practical & Conceptual” This study observed that post-COVID-19 telogen effluvium is more common among those with anemia, but was not linked to the severity of the initial infection.
July 2023 in “Zenodo (CERN European Organization for Nuclear Research)” In this review, researchers reported that post-COVID-19 syndrome may lead to significant sequelae like hair loss, potentially due to acute telogen effluvium, affecting around 20% of patients and impacting their quality of life, though specific studies on this relationship are lacking.
April 2023 in “Clinical dermatology review” This study found that 72% of patients who recovered from COVID-19 during the second wave reported experiencing significant hair loss, characteristic of telogen effluvium.